Literature DB >> 6891346

Forskolin requires more than the catalytic unit to activate adenylate cyclase.

D Stengel, L Guenet, M Desmier, P Insel, J Hanoune.   

Abstract

Forskolin, a natural diterpene, is a novel, potent activator of a variety of adenylate cyclase systems; its mechanism and site of action are still disputed. We report here that, while forskolin activates liver adenylate cyclase up to 15-fold, it does not activate cyclase of ram sperm which comprises a pure catalytic subunit. However, forskolin activation of sperm adenylate cyclase activity could be observed after reconstitution with the regulatory component-enriched membrane from human erythrocytes. The diterpene weakly (3-5-fold) activated the cytosolic, soluble cyclase found in rat and ram tests, but this effect was lost when the cyclase was purified by gel chromatography. Our data are not compatible with the hypothesis that forskolin acts directly on the catalytic subunit, but rather suggest that it acts via another regulatory component, part of, or different from, the GTP-binding regulatory complex.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6891346     DOI: 10.1016/0303-7207(82)90155-1

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  14 in total

Review 1.  Role of soluble adenylyl cyclase in the heart.

Authors:  Jonathan Chen; Lonny R Levin; Jochen Buck
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-11-04       Impact factor: 4.733

2.  Antagonist interaction with the human 5-HT(7) receptor mediates the rapid and potent inhibition of non-G-protein-stimulated adenylate cyclase activity: a novel GPCR effect.

Authors:  M T Klein; M Teitler
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

3.  Binding of [3H]forskolin to rat brain membranes.

Authors:  K B Seamon; R Vaillancourt; M Edwards; J W Daly
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

Review 4.  Adenylate cyclase and membrane fluidity. The repressor hypothesis.

Authors:  R Salesse; J Garnier
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

5.  Pathogenesis of nephrogenic diabetes insipidus due to chronic administration of lithium in rats.

Authors:  S Christensen; E Kusano; A N Yusufi; N Murayama; T P Dousa
Journal:  J Clin Invest       Date:  1985-06       Impact factor: 14.808

6.  Chronic norepinephrine elicits desensitization by uncoupling the beta-receptor.

Authors:  D E Vatner; S F Vatner; J Nejima; N Uemura; E E Susanni; T H Hintze; C J Homcy
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

7.  Vasoactive-intestinal-polypeptide-stimulated adenosine 3',5'-cyclic monophosphate accumulation in GH3 pituitary tumour cells. Reversal of desensitization by forskolin.

Authors:  S Guild; A H Drummond
Journal:  Biochem J       Date:  1984-08-01       Impact factor: 3.857

8.  Characterization of forskolin binding sites in rat brain membranes using [14,15-3H]14,15-dihydroforskolin as a ligand.

Authors:  K Schmidt; R Munshi; H P Baer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-02       Impact factor: 3.000

9.  Effect of forskolin on islet cyclic AMP, insulin secretion, blood glucose and intravenous glucose tolerance in rats.

Authors:  H P Ammon; A B Müller
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-07       Impact factor: 3.000

10.  Secretin-induced changes in rate, contractility and adenylate cyclase activity in rat heart atria.

Authors:  P Robberecht; P De Neef; M Waelbroeck; J C Camus; J Fontaine; J Christophe
Journal:  Pflugers Arch       Date:  1984-05       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.